RA Nash
- Hematology top 1%
- Hematopoietic Stem Cell Transplantation 19
- Platelet Disorders and Treatments 5
- Transplantation top 2%
- Immunology top 5%
- Immune Response and Inflammation 5
- T-cell and B-cell Immunology 4
- Genetics top 5%
- Virus-based gene therapy research 4
- Mesenchymal stem cell research 4
- Oncology top 10%
- Polyomavirus and related diseases 4
-
- Xenotransplantation and immune response 3
- Co-authors
- Rainer StorbClaudio AnasettiH. Joachim DeegK DoneyFR AppelbaumMary PettingerGary LongtonM. S. Pepe
- Cited by
- HematologyTransplantationImmunology
- Journals
- Blood (21 papers)Bone Marrow Transplantation (2 papers)Antimicrobial Agents and Chemotherapy (1 paper)
- Partner nations
- United StatesSouth AfricaKenya
In The Last Decade
RA Nash
33 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 69
- Hematology 948
- Transplantation 164
- Immunology 521
- Genetics 200
- Oncology 272
Countries citing papers authored by RA Nash
This map shows the geographic impact of RA Nash's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by RA Nash with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites RA Nash more than expected).
Fields of papers citing papers by RA Nash
This network shows the impact of papers produced by RA Nash. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by RA Nash. The network helps show where RA Nash may publish in the future.
Co-authorship network
The 25 scholars most cited alongside RA Nash, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 59 | |
| 2 | 2009 | 17 | |
| 3 | Special report Collection of hematopoietic stem cells from patients with autoimmune diseases | 2001 | 2 |
| 4 | 2000 | 8 | |
| 5 | Delay of radiation-induced decline and recovery of hematopoiesis following treatment with anti-HLA-DR antibody. | 1996 | 2 |
| 6 | 1996 | 4 | |
| 7 | Effects of rhIL-11 on normal dogs and after sublethal radiation. | 1995 | 28 |
| 8 | 1995 | 77 | |
| 9 | 1995 | 5 | |
| 10 | FK 506-based immunosuppression for prevention of graft versus host disease after unrelated donor marrow transplantation. | 1995 | 14 |
| 11 | 1995 | 36 | |
| 12 | 1994 | 79 | |
| 13 | 1994 | 5 | |
| 14 | 1993 | 57 | |
| 15 | 1992 | 29 | |
| 16 | 1991 | 20 | |
| 17 | 1991 | 6 | |
| 18 | Stimulation of canine hematopoiesis by recombinant human granulocyte-macrophage colony-stimulating factor. | 1989 | 19 |
| 19 | 1988 | 8 | |
| 20 | 1988 | 53 |
About RA Nash
RA Nash is a scholar working on Hematology, Transplantation, Immunology, Genetics and Sensory Systems, having authored 33 papers that have together received 1.4k indexed citations. Recurring topics across this work include Hematopoietic Stem Cell Transplantation (19 papers), Platelet Disorders and Treatments (5 papers), Immune Response and Inflammation (5 papers), Virus-based gene therapy research (4 papers), Mesenchymal stem cell research (4 papers), Polyomavirus and related diseases (4 papers), T-cell and B-cell Immunology (4 papers) and Xenotransplantation and immune response (3 papers). The work is most often cited by research in Hematology (948 citations), Transplantation (164 citations), Immunology (521 citations), Genetics (200 citations) and Oncology (272 citations). RA Nash has collaborated with scholars based in United States, South Africa and Kenya. Frequent co-authors include Rainer Storb, Claudio Anasetti, H. Joachim Deeg, K Doney, FR Appelbaum, Mary Pettinger, Gary Longton, M. S. Pepe, RA Bowden and M Pepe. Their work appears in journals such as Blood, Bone Marrow Transplantation, Antimicrobial Agents and Chemotherapy, The Journal of Infectious Diseases and American Journal of Transplantation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.